These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 17269156)
1. Five years on...and four challenges for the pharmaceutical industry. Nat Rev Drug Discov; 2007 Jan; 6(1):3. PubMed ID: 17269156 [No Abstract] [Full Text] [Related]
2. Overcoming the challenges in the pharma/biotech industry. Graul AI; Prous JR Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900 [TBL] [Abstract][Full Text] [Related]
3. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 1. Kuhrt K; Chace-Ortiz M IDrugs; 2009 Dec; 12(12):760-4. PubMed ID: 19943217 [TBL] [Abstract][Full Text] [Related]
4. Surviving the blockbuster syndrome. Service RF Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490 [No Abstract] [Full Text] [Related]
5. Are we living in the end of the blockbuster drug era? Debnath B; Al-Mawsawi LQ; Neamati N Drug News Perspect; 2010 Dec; 23(10):670-84. PubMed ID: 21180653 [TBL] [Abstract][Full Text] [Related]
6. An Indian effort towards affordable drugs: "generic to designer drugs". Taneja B; Yadav J; Chakraborty TK; Brahmachari SK Biotechnol J; 2009 Mar; 4(3):348-60. PubMed ID: 19296440 [No Abstract] [Full Text] [Related]
7. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening]. Schirlin D; Galvan M; Le Fur G Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426 [TBL] [Abstract][Full Text] [Related]
8. Overcoming the obstacles in the pharma/biotech industry: 2008 update. Graul AI; Revel L; Rosa E; Cruces E Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298 [TBL] [Abstract][Full Text] [Related]
9. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 2. Kuhrt K IDrugs; 2009 Dec; 12(12):765-9. PubMed ID: 19943218 [TBL] [Abstract][Full Text] [Related]
10. Indian biogenerics industry emerges. Jayaraman KS Nat Biotechnol; 2003 Oct; 21(10):1115-6. PubMed ID: 14520378 [No Abstract] [Full Text] [Related]
11. The ongoing regulation of generic drugs. Frank RG N Engl J Med; 2007 Nov; 357(20):1993-6. PubMed ID: 18003956 [No Abstract] [Full Text] [Related]
12. Reinventing an industry. Mandavilli A Nature; 2007 Jan; 445(7124):138-9. PubMed ID: 17215817 [No Abstract] [Full Text] [Related]
13. Biotechs go generic: the same but different. Ledford H Nature; 2007 Sep; 449(7160):274-6. PubMed ID: 17882194 [No Abstract] [Full Text] [Related]
15. Handle with care. Macilwain C Nature; 2006 Apr; 440(7087):990-1. PubMed ID: 16625170 [No Abstract] [Full Text] [Related]
16. Betting on biogenerics. Dove A Nat Biotechnol; 2001 Feb; 19(2):117-20. PubMed ID: 11175723 [No Abstract] [Full Text] [Related]
17. Blockbuster drug bows out. Ledford H Nature; 2011 Nov; 480(7375):16-7. PubMed ID: 22129701 [No Abstract] [Full Text] [Related]
18. Current trends in the pharmaceutical industry--a case study approach. Rusu A; Kuokkanen K; Heier A Eur J Pharm Sci; 2011 Oct; 44(3):437-40. PubMed ID: 21782941 [TBL] [Abstract][Full Text] [Related]
19. [Discount for only one drug of the same group leads to impaired health care quality]. Bergström R Lakartidningen; 2006 Feb 8-14; 103(6):387-8; discussion 388. PubMed ID: 16536044 [No Abstract] [Full Text] [Related]